Volume 20, Number 4—April 2014
Research
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
Table 1
Association between rates of mumps complications and hospitalization and MMR status, the Netherlands, September 1, 2009–August 31, 2012*
Complication | No. MMR doses received by case-patient | No. (%) case-patients with complications | Crude OR (95% CI) | p value | aOR† (95%CI) | p value | aVE† (95% CI) |
---|---|---|---|---|---|---|---|
Orchitis§ | 0 | 36 (15.5) | Ref | Ref | Ref | Ref | |
1 | 10 (6.6) | 0.46 (0.22–0.97) | 0.04 | 0.46 (0.22–0.98) | 0.04 | 54 (2–78) | |
2 | 46 (4.7) | 0.26 (0.16–0.41) | <0.01 | 0.26 (0.15–0.43) | <0.01 | 74 (57–85) | |
Deafness | 0 | 2 (0.9) | Ref | ||||
1 | 0 | NA | NA | – | – | – | |
2 | 1 (0.1) | 0.12 (0.01–1.3) | 0.1 | – | – | – | |
Meningitis | 0 | 2 (0.8) | Ref | ||||
1 | 1 (0.6) | 0.76 (0.07–8.5) | 0.8 | – | – | – | |
2 | 2 (0.2) | 0.24 (0.03–1.7) | 0.2 | – | – | – | |
All complications | 0 | 44 (19.0) | Ref | Ref | Ref | Ref | |
1 | 10 (6.6) | 0.30 (0.15–0.62) | <0.01 | 0.29 (0.14–0.62) | <0.01 | 71 (38–86) | |
2 | 55 (5.7) | 0.26 (0.17–0.39) | <0.01 | 0.24 (0.14–0.39) | <0.01 | 76 (61–86) | |
Hospitalization | 0 | 11 (4.8) | Ref | Ref | Ref | Ref | |
1 | 3 (2.0) | 0.41 (0.11–1.5) | 0.18 | 0.43 (0.11–1.6) | 0.2 | 57 (–60 to 89) | |
2 | 10 (1.1) | 0.22 (0.09–0.52) | <0.01 | 0.18 (0.07–0.47) | <0.01 | 82 (53–93) |
*Only case-patients with known complications and vaccination status were included in the analyses. OR, odds ratio; VE, vaccine effectiveness; Ref, referent; NA, not applicable; –, not analyzed (insufficient sample size).
†Adjusted for age (age groups <18 y, 18–25 y, >25 y) and sex, except orchitis, which was adjusted only for age.
§Includes only male case-patients >12 y of age.